William F. Benedict
- Ophthalmology top 0.2%
- Ocular Oncology and Treatments 38
- Oncology top 0.5%
- Cancer-related Molecular Pathways 67
- Cancer Research top 0.5%
- Carcinogens and Genotoxicity Assessment 12
- Biotechnology top 0.5%
- Cancer Research and Treatments 27
- Molecular Biology top 1%
- DNA Repair Mechanisms 13
- Ubiquitin and proteasome pathways 12
-
- Bladder and Urothelial Cancer Treatments 32
-
- Virus-based gene therapy research 21
- Co-authors
- A. Linn MurphreePeter A. JonesHong XuAshutosh BanerjeeShi‐Xue HuWen‐Hwa LeeWalter E. LaugJin Qian
- Cited by
- OphthalmologyOncologyCancer Research
- Partner nations
- United StatesSpainJapan
In The Last Decade
William F. Benedict
171 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Ophthalmology 1.6k
- Oncology 4.5k
- Cancer Research 2.1k
- Biotechnology 778
- Molecular Biology 5.2k
Countries citing papers authored by William F. Benedict
This map shows the geographic impact of William F. Benedict's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Benedict with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Benedict more than expected).
Fields of papers citing papers by William F. Benedict
This network shows the impact of papers produced by William F. Benedict. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Benedict. The network helps show where William F. Benedict may publish in the future.
Co-authorship network
The 25 scholars most cited alongside William F. Benedict, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 30 | |
| 2 | 2014 | 10 | |
| 3 | 2011 | 10 | |
| 4 | 2007 | 20 | |
| 5 | 2006 | 15 | |
| 6 | 2005 | 40 | |
| 7 | 2004 | 230 | |
| 8 | 2001 | 23 | |
| 9 | 2001 | 40 | |
| 10 | 2000 | 6 | |
| 11 | 1997 | 27 | |
| 12 | 1997 | 9 | |
| 13 | 1996 | 59 | |
| 14 | 1994 | 179 | |
| 15 | 1994 | 9 | |
| 16 | 1990 | 12 | |
| 17 | Cyclophosphamide-induced oncogenic transformation, chromosomal breakage, and sister chromatid exchange following microsomal activation. | 1978 | 41 |
| 18 | Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines. | 1977 | 206 |
| 19 | Oncogenic transformation of C3H/10T1/2 clone 8 mouse embryo cells by halogenated pyrimidine nucleosides. | 1976 | 56 |
| 20 | Chromosomal damage as a screen for carcinogenic/mutagenic potential of anticancer drugs | 1976 | 1 |
About William F. Benedict
William F. Benedict is a scholar working on Ophthalmology, Biotechnology and Oncology, having authored 172 papers that have together received 10.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (67 papers), Ocular Oncology and Treatments (38 papers), Bladder and Urothelial Cancer Treatments (32 papers), Cancer Research and Treatments (27 papers), Virus-based gene therapy research (21 papers), DNA Repair Mechanisms (13 papers), Ubiquitin and proteasome pathways (12 papers) and Carcinogens and Genotoxicity Assessment (12 papers). The work is most often cited by research in Ophthalmology (1.6k citations), Oncology (4.5k citations) and Cancer Research (2.1k citations). William F. Benedict has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include A. Linn Murphree, Peter A. Jones, Hong Xu, Ashutosh Banerjee, Shi‐Xue Hu, Wen‐Hwa Lee, Walter E. Laug, Jin Qian, Steven H. Hinrichs and Colin P. Dinney. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.